Lifecore Biomedical, Inc. (LFCR) Q1 2024 Annual Earnings
LFCR·Reported May 22, 2024·Before market open
Lifecore Biomedical, Inc. reported Q1 2024 revenue of $35.7M, beat analyst consensus of $24.4M by $11.3M. Diluted EPS came in at $0.43, beat the $-0.23 consensus by $0.66.
Revenue
$35.7Mbeat by $11.3M
Consensus: $24.4MDiluted EPS
$0.43beat by $0.66
Consensus: $-0.23
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Lifecore Biomedical, Inc.'s Q1 2024 earnings report.
Lifecore Biomedical, Inc. (LFCR) reported Q1 2024 earnings on May 22, 2024 before market open.
Lifecore Biomedical, Inc. reported revenue of $35.7M and diluted EPS of $0.43 for Q1 2024.
Revenue beat the consensus estimate of $24.4M by $11.3M. EPS beat the consensus estimate of $-0.23 by $0.66.
You can read the 10-K periodic report (0001005286-24-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.